| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 03/31/2011 | US20110077288 Pharmaceutical Compositions for Treatment of MicroRNA Related Diseases |
| 03/31/2011 | US20110077287 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions |
| 03/31/2011 | US20110077286 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof |
| 03/31/2011 | US20110077285 Rna antagonist compounds for the modulation of pik3ca expression |
| 03/31/2011 | US20110077283 Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| 03/31/2011 | US20110077223 Chimeric promoters for use in plants |
| 03/31/2011 | US20110077210 Hdac regulation assays, compounds and therapeutic compositions |
| 03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/31/2011 | US20110077206 Use of hnf4alpha for treatment of human malignant solid tumors through induction-differentiation therapy |
| 03/31/2011 | US20110077199 Growth hormone polypeptides and methods of making and using same |
| 03/31/2011 | US20110077197 Novel insulin derivatives having an extremely delayed time-action profile |
| 03/31/2011 | US20110077196 Non-standard insulin analogues |
| 03/31/2011 | US20110077173 siRNA targeting TIE-2 |
| 03/31/2011 | US20110077170 Hpiv-2 variants and their medical applications |
| 03/31/2011 | US20110076761 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 03/31/2011 | US20110076742 Polynucleotides encoding novel pcsk9 variants |
| 03/31/2011 | US20110076741 Alpha-amylase variants |
| 03/31/2011 | US20110076740 Amylases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 03/31/2011 | US20110076739 Catalytic domains from lysyl oxidase and loxl2 |
| 03/31/2011 | US20110076731 promoter, and a production method for l-lysine using the same |
| 03/31/2011 | US20110076730 Microbial synthesis of d-1,2,4-butanetriol |
| 03/31/2011 | US20110076726 Differential enzymatic fragmentation by whole genome amplification |
| 03/31/2011 | US20110076723 Antibody-peptide fused synergibody |
| 03/31/2011 | US20110076718 In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group |
| 03/31/2011 | US20110076707 Mutant glucose dehydrogenase |
| 03/31/2011 | US20110076705 Compositions and methods for early pregnancy diagnosis |
| 03/31/2011 | US20110076699 Hemolysin and its protein fragments in sero-detection of anaplasma phagocytophilum |
| 03/31/2011 | US20110076689 PRIMER FOR DETECTING TYROSINASE mRNA |
| 03/31/2011 | US20110076685 Method for in vitro detection and differentiation of pathophysiological conditions |
| 03/31/2011 | US20110076681 Modified gene-silencing nucleic acid molecules and uses thereof |
| 03/31/2011 | US20110076673 Detection of bacteria |
| 03/31/2011 | US20110076302 Plant-derived vaccines against respiratory syncytial virus |
| 03/31/2011 | US20110076301 Antigenic protein fragments of streptococcus pneumoniae |
| 03/31/2011 | US20110076300 Hybrid Polypeptides Including Meningococcal fHBP Sequences |
| 03/31/2011 | US20110076299 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/31/2011 | US20110076298 Soluble stabilized trimeric hiv env proteins and uses thereof |
| 03/31/2011 | US20110076289 Transgenic animal model of neurodegenerative disorders |
| 03/31/2011 | US20110076283 Method for predicting and diagnosing brain tumor |
| 03/31/2011 | US20110076279 Fully human anti-vegf antibodies and methods of using |
| 03/31/2011 | US20110076275 Method of Modifying Isoelectric Point of Antibody Via Amino Acid Substitution in CDR |
| 03/31/2011 | US20110076268 Antibodies against human respiratory syncytial virus (RSV) and methods of use |
| 03/31/2011 | US20110076267 Humanized antibody compositions and methods for binding lysophosphatidic acid |
| 03/31/2011 | US20110076265 Monoclonal antibodies having homosubtype cross-neutralization properties against influenza a viruses subtype h1 |
| 03/31/2011 | US20110076263 Endoglin Antibodies |
| 03/31/2011 | US20110076262 Humanized anti-fgf19 antagonists and methods using same |
| 03/31/2011 | US20110076260 Proteases Producing an Altered Immunogenic Response and Methods of Making and Using the Same |
| 03/31/2011 | US20110076257 Modified Nucleotide Sequence Encoding Glucagon-Like Peptide-1 (GLP-1), Nucleic Acid Construct Comprising Same for Production of Glucagon-Like Peptide-1 (GLP-1), Human Cells Comprising Said Construct and Insulin-Producing Constructs, and Method of Use Thereof |
| 03/31/2011 | US20110076251 Novel therapeutic agents against hepatitis |
| 03/31/2011 | US20110076235 Genes, methods, and compositions related to neurogenesis and its modulation |
| 03/31/2011 | CA2775092A1 Compositions and methods for silencing genes expressed in cancer |
| 03/30/2011 | EP2302079A2 Systemic lupus erythematosus diagnostic assay |
| 03/30/2011 | EP2302074A1 Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy |
| 03/30/2011 | EP2302059A1 Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 03/30/2011 | EP2302039A1 Virus-like particles comprising HML-2 gag polypeptide |
| 03/30/2011 | EP2302031A1 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms |
| 03/30/2011 | EP2301966A1 Immunoglobulin variants and uses thereof |
| 03/30/2011 | EP2301965A1 Antibodies that bind cell-associated CA 125/0722P and methods of use thereof |
| 03/30/2011 | EP2301958A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 03/30/2011 | EP2301949A1 Genetically modified yeast species and fermentation processes using genetically modified yeast |
| 03/30/2011 | EP2301948A1 Promoters for regulation of gene expression in plant roots |
| 03/30/2011 | EP2301947A2 Secreted proteins and uses thereof |
| 03/30/2011 | EP2301582A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/30/2011 | EP2300488A1 Cell lysis reagent for isolation of rna |
| 03/30/2011 | EP1294930B1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/30/2011 | CN101999003A Method for isolating cell free apoptotic or fetal nucleic acids |
| 03/30/2011 | CN101999002A Methods of diagnosing and treating PARP-mediated diseases |
| 03/30/2011 | CN101999001A Disease markers and uses thereof |
| 03/30/2011 | CN101993472A Miniature multifunctional large biological molecule separating and purifying device |
| 03/30/2011 | CN101993467A Method of manipulating the surface density of functional molecules on nanoparticles |
| 03/30/2011 | CN101294162B P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 03/30/2011 | CN101100479B Method for extracting residual DNA in edible vegetable oil |
| 03/29/2011 | US7917304 Spotter provided with spot pattern encryption function and detection device coping with spot pattern encryption |
| 03/29/2011 | US7915487 Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same |
| 03/29/2011 | US7915486 Plastidic phosphoglucomutase genes |
| 03/29/2011 | US7915485 Nodulation factor binding element for use in developing nitrogen-fixing root nodules in plants |
| 03/29/2011 | US7915483 C-terminally truncated interferon |
| 03/29/2011 | US7915482 Anther specific promoters and uses thereof |
| 03/29/2011 | US7915481 Maize ETR2 gene and uses thereof |
| 03/29/2011 | US7915401 Compounds for the modulation of beta-catenin expression |
| 03/29/2011 | US7915400 RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA) |
| 03/29/2011 | US7915399 Modified siRNA molecules and uses thereof |
| 03/29/2011 | US7915396 Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49 |
| 03/29/2011 | US7915395 Plasmid coding immunogenic fusion protein for use as drug delivery tool; antiproliferative agents; genetic vaccines |
| 03/29/2011 | US7915394 Alleles of the OpcA gene from coryneform bacteria |
| 03/29/2011 | US7915392 5-bromo-2′-deoxy-uridine labeled nucleotide triphosphates and nucleic acid probes and methods of making and using the same |
| 03/29/2011 | US7915231 Antisense modulation of C-reactive protein expression |
| 03/29/2011 | US7915042 Keratinocytes expressing exogenous angiogenic growth factors |
| 03/29/2011 | US7915036 Compositions comprising T cell receptors and methods of use thereof |
| 03/29/2011 | US7915035 Vaccine against oncovirus infections such as infections by feline leukosis virus of the cat |
| 03/29/2011 | US7915031 DNA fragments array from biomining microorganisms and method for detection of them |
| 03/29/2011 | US7915026 Host cells for production of isoprenoid compounds |
| 03/29/2011 | US7915021 Mutant firefly luciferase |
| 03/29/2011 | US7915016 Recovering and replicating RNA sequences from preferential tissues; organ specific RNA libraries |
| 03/29/2011 | US7915015 Digital amplification |
| 03/29/2011 | US7915010 DNA molecules encoding L-glutamate-gated chloride channels from Rhipicephalus sanguineus |
| 03/29/2011 | US7914997 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 03/29/2011 | US7914996 Polynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide |
| 03/29/2011 | US7914991 Nucleolipids and use thereof, and devices for nucleic acid analysis |
| 03/29/2011 | US7914989 Capture moieties for nucleic acids and uses thereof |
| 03/29/2011 | US7914987 Methods and compositions for use in analyte detection using proximity probes |